Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial
Abroad (travel likely)RecruitingPHASE2
Conditions
Von Hippel Lindau · Von Hippel Lindau Disease · Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma · Hemangioblastoma (HB) of the Central Nervous System (CNS) · PNET · Retinal Angiomatous Proliferation · Pheochromocytoma/Paraganglioma · Endolymphatic Sac Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
AC Camargo Cancer Center, São Paulo, São Paulo, Brazil
Contact: Study coordinator (Giovana Tardin Torrezan, Research Coordinator) · cep_accamargo@accamargo.org.br · +55 11 2189 5020Contact: Study coordinator (Sandra Almeida, Administrative CEP) · cep_accamargo@accamargo.org.br · +55 11 2189 5020Contact: Principal Investigator (José Claudio Casali da Rocha, Head of Oncogenetics)José Reinaldo De Oliveira Junior (Sub-investigator)